The Impact of COVID-19 on the Optimal Management of Osteoporosis
Sung Hye Kong, Bo Kwon Hwang, Byung-Ho Yoon
J Bone Metab. 2021;28(2):115-122.   Published online 2021 May 31     DOI:
Citations to this article as recorded by Crossref logo
A 2-year follow-up of a novel Fracture Liaison Service: can we reduce the mortality in elderly hip fracture patients? A prospective cohort study
D. González-Quevedo, V. Pérez-del-Río, D. Moriel-Garceso, N. Fernández-Arroyabe, G. García-Meléndez, M. Montañez-Ruiz, M. Bravo-Bardají, D. García-de-Quevedo, I. Tamimi
Osteoporosis International.2022; 33(8): 1695.     CrossRef
Arthritis with osteoporosis crippled the elderly during Covid-19 pandemic: A silent killer?
Gaurav Govil, Lavindra Tomar, Pawan Dhawan
IP International Journal of Orthopaedic Rheumatology.2022; 8(1): 38.     CrossRef
Dispensing anti-osteoporotic drugs changed during the COVID-19 pandemic
Roland Kocijan, Theresa Stockinger, Judith Haschka, Berthold Reichardt, Heinrich Resch, Jochen Zwerina, Martina Behanova
Bone.2022; 162: 116477.     CrossRef
Osteoporosis in Patients With Respiratory Diseases
Yue Ma, Shui Qiu, Renyi Zhou
Frontiers in Physiology.2022;[Epub]     CrossRef
Effects of COVID-19 confinement on the incidence and mortality of major osteoporotic fractures: an observational study in Catalonia, Spain
Xavier Surís, Emili Vela, Montserrat Clèries, Esteve Llargués, Jordi Camins, Marta Larrosa
Archives of Osteoporosis.2022;[Epub]     CrossRef